Trulieve Cannabis Corp. SEC filings TRLV

Trulieve Cannabis Corp. has 416 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Trulieve Cannabis Corp. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
S-8 POS Filing Aug 24, 2026 —
POSASR Filing Aug 24, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Aug 11, 2026 Aug 11, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Aug 7, 2026 Aug 7, 2026
8-K Current report
Shareholder vote results
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 2, 2026 Jun 30, 2026
DEF 14A Proxy statement Jun 25, 2026 Jun 25, 2026
DEFA14A Additional proxy material Jun 25, 2026 —
PRE 14A Preliminary proxy statement Jun 12, 2026 Jun 8, 2026
8-K Current report
Officer or director change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
CERT Nyse certification Jun 9, 2026 —
8-K Current report
Other events
Jun 9, 2026 Jun 9, 2026
8-A12B Filing Jun 9, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets
Jun 4, 2026 Jun 3, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Apr 21, 2026 Apr 15, 2026
8-K Current report
Officer or director change
Mar 5, 2026 Feb 27, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Feb 18, 2026 Feb 12, 2026
D Filing Feb 6, 2026 —
8-K Current report
Material agreement, New debt, Other events
Jan 29, 2026 Jan 29, 2026
D Filing Dec 29, 2025 —
8-K Current report
Material agreement, New debt, Other events
Dec 17, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 9, 2025 Dec 8, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 27, 2025 Aug 27, 2025
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
S-3ASR Automatic shelf registration Jun 30, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 12, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2025 May 7, 2025
DEFR14A Filing Apr 30, 2025 —
DEFA14A Additional proxy material Apr 29, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Dec 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 7, 2025 Mar 6, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2024 Nov 5, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
S-8 Employee stock plan registration Jun 21, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2024 Jun 12, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 30, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 30, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Apr 23, 2024 Apr 17, 2024
8-K Current report
Auditor change
Mar 29, 2024 Mar 25, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 29, 2024 Feb 29, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 18, 2024 Jan 17, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 22, 2023 Dec 22, 2023
8-K Current report
Other events
Dec 1, 2023 Dec 1, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Nov 8, 2023 Nov 8, 2023
8-K Current report
Regulation FD disclosure
Oct 13, 2023 Oct 13, 2023
8-K Current report
Regulation FD disclosure
Sep 21, 2023 Sep 21, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2023 Aug 9, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 21, 2023 Jul 20, 2023
S-8 Employee stock plan registration Jun 28, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 20, 2023 Jun 18, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2023 Jun 14, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2023 May 10, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 1, 2023 Apr 26, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
UPLOAD Letter from the SEC Apr 11, 2023 —
8-K Current report
Other events
Apr 5, 2023 Apr 5, 2023
CORRESP Letter to the SEC Apr 5, 2023 —
10-K/A Amended annual report Apr 5, 2023 Dec 31, 2021
UPLOAD Letter from the SEC Mar 15, 2023 —
10-K Annual report Mar 8, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 8, 2023 Mar 8, 2023
10-K/A Amended annual report Mar 8, 2023 Dec 31, 2021
NT 10-K Filing Feb 24, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Jan 13, 2023 Jan 10, 2023
CORRESP Letter to the SEC Jan 10, 2023 —
UPLOAD Letter from the SEC Dec 23, 2022 —
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Dec 21, 2022 Dec 21, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2022 Nov 9, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 10, 2022 Aug 10, 2022
EFFECT Filing Jul 11, 2022 —
EFFECT Filing Jul 11, 2022 —
FWP Free writing prospectus Jul 8, 2022 —
S-3ASR Automatic shelf registration Jul 8, 2022 —
POS AM Filing Jul 7, 2022 —
POS AM Filing Jul 7, 2022 —
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 8, 2022
8-K/A Amended current report
Officer or director change
May 24, 2022 Mar 31, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2022 May 12, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 17, 2022
8-K Current report
Officer or director change
Apr 5, 2022 Mar 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2022 Mar 30, 2022
424B3 Prospectus Jan 31, 2022 —
8-K Current report
New debt, Regulation FD disclosure
Jan 31, 2022 Jan 28, 2022
EFFECT Filing Jan 28, 2022 —
CORRESP Letter to the SEC Jan 26, 2022 —
EFFECT Filing Jan 25, 2022 —
UPLOAD Letter from the SEC Jan 25, 2022 —
S-1 Registration statement Jan 21, 2022 —
POS AM Filing Jan 21, 2022 —
8-K Current report
Officer or director change
Dec 29, 2021 Dec 24, 2021
8-K/A Amended current report Dec 17, 2021 Oct 1, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2021 Nov 15, 2021
D Filing Oct 13, 2021 —
8-K Current report
Regulation FD disclosure
Oct 12, 2021 Oct 12, 2021
8-K Current report
Material agreement, New debt, Other events
Oct 8, 2021 Oct 6, 2021
S-8 Employee stock plan registration Oct 6, 2021 —
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Oct 1, 2021 Oct 1, 2021
8-K Current report
Other events
Sep 30, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Sep 30, 2021 Sep 28, 2021
EFFECT Filing Sep 20, 2021 —
8-K Current report
Unregistered share sale, Officer or director change
Sep 17, 2021 Sep 15, 2021
POS AM Filing Sep 15, 2021 —
S-8 Employee stock plan registration Aug 30, 2021 —
8-K Current report
Regulation FD disclosure
Aug 24, 2021 Aug 24, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Auditor change
Jul 7, 2021 Jul 2, 2021
D Filing Jun 23, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2021 Jun 10, 2021
8-K Current report
Regulation FD disclosure
Jun 4, 2021 Jun 4, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
8-K Current report
Regulation FD disclosure, Other events
May 10, 2021 May 10, 2021
DEFA14A Additional proxy material Apr 21, 2021 —
DEF 14A Proxy statement Apr 21, 2021 Jun 10, 2021
AW Filing Apr 8, 2021 —
424B4 Prospectus Apr 8, 2021 —
POS EX Filing Apr 8, 2021 —
POS AM Post-effective amendment no. 1 to form s-1 Apr 8, 2021 —
EFFECT Filing Apr 7, 2021 —
CORRESP Letter to the SEC Apr 5, 2021 —
CORRESP Letter to the SEC Apr 5, 2021 —
S-1 Registration statement Apr 5, 2021 —
EFFECT Filing Mar 29, 2021 —
POS AM Filing Mar 23, 2021 —
10-K Annual report Mar 23, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 23, 2021 Mar 23, 2021
UPLOAD Letter from the SEC Feb 11, 2021 —
424B3 Prospectus Feb 8, 2021 —
EFFECT Filing Feb 4, 2021 —
CORRESP Letter to the SEC Feb 2, 2021 —
8-A12G Form 8-a12g Feb 2, 2021 —
S-1/A Amended registration statement Feb 2, 2021 —
CORRESP Letter to the SEC Jan 12, 2021 —
S-1 Registration statement Jan 12, 2021 —
UPLOAD Letter from the SEC Dec 28, 2020 —
DRS/A Filing Dec 11, 2020 —
UPLOAD Letter from the SEC Nov 20, 2020 —
DRS Filing Oct 22, 2020 —
D Filing Oct 2, 2018 —

Showing 178 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
TRLV (NYSE)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Tallahassee, FL
SEC filer status
Large accelerated filer
SEC CIK
1754195

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.